Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas

Predicting the likelihood of early recurrence based on mRNA sequencing of pituitary adenomas

(2020) Xi Wang et al.   Gland Surgery

In silico analysis of the immunological landscape of pituitary adenomas

(2020) Jacky T. Yeung et al.   JOURNAL OF NEURO-ONCOLOGY

Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes

(2019) Sarah E. Nicholas et al.   Frontiers in Oncology

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors

(2019) Sayka Barry et al.   ONCOGENE

Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease

(2019) Hanna R Kemeny et al.   CLINICAL CANCER RESEARCH

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

(2019) Pedro Marques et al.   Acta Neuropathologica Communications

The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes

(2018) Matthew P. Salomon et al.   CLINICAL CANCER RESEARCH

The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy

(2018) Peng-fei Wang et al.   JOURNAL OF NEURO-ONCOLOGY

Silent somatotroph pituitary adenomas: an update

(2018) Fabienne Langlois et al.   Pituitary

Silent corticotroph adenomas

(2018) Anat Ben-Shlomo et al.   Pituitary

Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab

(2018) Andrew L Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

(2018) Bagher Farhood et al.   JOURNAL OF CELLULAR PHYSIOLOGY

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity

(2017) Vikram R. Juneja et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Function of cell‑cycle regulators in predicting silent pituitary adenoma progression following surgical resection

(2017) Sung Hyun Park et al.   Oncology Letters

Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data

(2017) Julien Racle et al.   eLife

Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples

(2017) Guanzhang Li et al.   OncoImmunology

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members

(2017) Yuan He et al.   Scientific Reports

CCR9 in cancer: oncogenic role and therapeutic targeting

(2016) Zhenbo Tu et al.   Journal of Hematology & Oncology

Management of aggressive growth hormone secreting pituitary adenomas

(2016) Daniel A. Donoho et al.   Pituitary

Association between single nucleotide polymorphisms in the TSPYL6 gene and breast cancer susceptibility in the Han Chinese population

(2016) Ming Liu et al.   Oncotarget

Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

(2016) Yu Mei et al.   Oncotarget

The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion

(2016) Erin A. Maine et al.   Oncotarget

The concept of immune surveillance against tumors: The first theories

(2016) Domenico Ribatti   Oncotarget

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

(2015) Michael S. Rooney et al.   CELL

Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas

(2015) Jian-Qiang Lu et al.   ENDOCRINE PATHOLOGY

Invasive, Atypical and Aggressive Pituitary Adenomas and Carcinomas

(2015) Aydin Sav et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Invasive adenoma and pituitary carcinoma: a SEER database analysis

(2014) Tara M. Hansen et al.   NEUROSURGICAL REVIEW

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

(2013) Jacqueline Trouillas et al.   ACTA NEUROPATHOLOGICA

Pituitary adenomas: Surgery and radiotherapy in the age of molecular diagnostics and pathology

(2013) Ian E. McCutcheon   CURRENT PROBLEMS IN CANCER

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

(2013) Gabriela Bindea et al.   IMMUNITY

Endocrine Side Effects Induced by Immune Checkpoint Inhibitors

(2013) Salvatore Maria Corsello et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

(2013) Charles G. Drake et al.   Nature Reviews Clinical Oncology

Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases

(2013) Muthulekha Swamydas et al.   Cell Adhesion & Migration

CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma

(2012) P. A. Prieto et al.   CLINICAL CANCER RESEARCH

Cancer-Related Inflammation

(2012) Juliana Candido et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity

(2011) Tomasz J. Slebioda et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Pituitary Carcinoma: Difficult Diagnosis and Treatment

(2011) Anthony P. Heaney   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)

(2009) Alberto Fernandez et al.   CLINICAL ENDOCRINOLOGY

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

(2008) L. G. Almeida et al.   NUCLEIC ACIDS RESEARCH